Propiedades psicométricas del inventario breve de fatiga en personas tratadas por neoplasias hematológicas en Chile / Assessment of a brief fatigue inventory in patients with hematologic malignancies
Rev. méd. Chile
;
144(7): 894-899, jul. 2016. tab
Artigo
em Espanhol
| LILACS
| ID: lil-794003
ABSTRACT
Background:
Fatigue is one of the most common and distressing symptoms experienced by cancer patients.Aim:
To validate the Brief Fatigue Inventory in people treated for hematological neoplasms. Material andMethods:
In a cross-sectional study, the Brief Fatigue Inventory was answered by 122 patients aged 40 ± 14 years (50% women) treated for hematological neoplasms at an intensive hematological unit of a public hospital between July 2010 and July 2013. Socio-demographic and clinical parameters were obtained from their clinical records.Results:
Fatigue was present in nearly all patients (99.2%) in minor (50%), moderate (36.9%) or severe (12.3%) levels. The average fatigue score was 4.5 ± 1.9). The Brief Fatigue Inventory had a good internal consistency (Cronbachs alpha = 0.973) and proved to be one-dimensional (84.3% of the explained variance). Women reported that fatigue interfered more with enjoyment of life than men (p = 0.036).Conclusions:
The Brief Fatigue Inventory is a reliable instrument that can be used in clinical practice. It allows a quick assessment of the level of fatigue. People treated for hematologic cancer have a high prevalence of fatigue.
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Assunto principal:
Neoplasias Hematológicas
/
Fadiga
Tipo de estudo:
Estudo de etiologia
/
Estudo observacional
/
Estudo de prevalência
/
Fatores de risco
Limite:
Adolescente
/
Adulto
/
Feminino
/
Humanos
/
Masculino
País/Região como assunto:
América do Sul
/
Chile
Idioma:
Espanhol
Revista:
Rev. méd. Chile
Assunto da revista:
Medicina
Ano de publicação:
2016
Tipo de documento:
Artigo
País de afiliação:
Chile
Instituição/País de afiliação:
Servicio de Salud Metropolitano Oriente/CL
Similares
MEDLINE
...
LILACS
LIS